Baker McKenzie advises on US$2.3 billion bond offering for Teva Pharmaceutical and concurrent tender offer

Baker McKenzie acted for a syndicate of 10 underwriters in the multi-tranche US$2.3 billion equivalent SEC registered bond offering by certain subsidiaries of Teva Pharmaceutical Industries Limited.